Impact of EU label changes and pregnancy prevention programme for medicinal products containing valproate and related substances: risk awareness and adherence (ValproateRiskAware)

Study protocol

Initial protocol

29-01-2020 Protocol valproate study version 2.0 final with annexes

English (634.51 KB - PDF) View document

Study results

ValproateRiskAware summary

English (196.49 KB - PDF) View document

Study report

ValproateRiskAware study report_revised final2

English (2.29 MB - PDF) View document

Other information

Secondary tabs